Raymond James Financial »

Vistagen Therapeutics Ord shares owned by Raymond James Financial

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.5k 15k 0.57
2025-06-30 $13k 6.4k 2.00

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p500 Etf (IVV)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Vistagen Therapeutics Ord

OrbiMed Advisors
TCG Crossover Management
Vanguard Capital Management
ADAR1 Capital Management
Millennium Management
Stempoint Capital
Acadian Asset Management
Ikarian Capital
Two Sigma Investments
Geode Capital Management
BlackRock
Luminus Management
Jane Street
Renaissance Technologies
AdvisorShares Investments

View all funds holding Vistagen Therapeutics Ord